bathtime

Reddit threads on soda consumption by people taking GLP-1s.

KO and PEP down big today. KO getting to a decent relative value? Near the cycle low forward P/E of 18 from last decade.

Congratulations on an excellent hedge and trade.

Are we around 1.4x BV near $350 on the B shares? Thanks.

Ah thanks, I like that equal weighted SPX idea. Up even less than VIG year to date. Will consider that.

VIG - Vanguard Dividend Appreciation ETF Intention is to preserve this year’s trading gains, reduce risk and lower trading velocity of my account by shifting some allocation to VIG as a core largest holding. Also to have a liquid, more stable source for funds for tax loss selling trade opportunities from October to December.

MSGS

Ditto -6.4%.

Magazine cover indicator?

At $105 after hours, net of cash, is not much over 2x sales. That seems decent if they can normalize earnings, capex, and margins over long term.

KIND at $2.85.

Have you worked with SNOW’s tech, @lnofeisone?

Would like to buy in 20s near IPO share price if March lockup creates sell pressure.

MA, DBX, V, IAC, DIS, TWTR

I feel grateful for having had success trading this year, AND, this week I’m feeling exhausted from the last 18 months of grinding out equity trades/investments. I wonder about just going to mostly cash and doing strategic options trades with 5-10% of the account, as a way to stay in the game but not risk the 90-95% of the account to a bursting bubble.

Congratulations on a great trade. Was researching PTON and saw it was rated as #1 brand. Above Apple, NetfIix, Costco, Chick-Fil-A, etc. I’m tempted to go long here. https://www.comparably.com/brands

In current climes it is, intentionally or not, probably an effective marketing strategy for gaining lots of followers. IMO Kuppy lives in a rich Miami bro bubble AND he’s a skilled stock picker.

Do you feel like volatility has increased in individual equities compared to 5 or 10 years ago? I feel like it has significantly. But maybe there are stats on that somewhere.

Well here’s Kuppy’s latest thinking out of the box

I think the plan is a combo of first to market w/FDA approval, anticipated patent on a specific formulation, and patents on specific indications for use.

I’ll add healthcare, in the vein of what Hemant Taneja is working on at General Catalyst. Then a subset of that is mental health. And a part of that is psychedelics for therapeutic use. I’m on the West coast and innovators in the therapeutic scene are pivoting towards integrating psychedelic therapeutics. Anyone own CMPS?

Ha. The fanboys think she’s going to make it a fintech, by moving into payments. But she threw cold water on that in a Tweet response and said it was an e-commerce company not a fintech. There was a time when everyone hated SNAP’s business prospects. So I’m wondering if WISH can pull off a transformation. Plenty of cash and they’re pulling way back on ad spend. Which is probably Reses’ counsel. New CFO is next move. If GME can moon from just ex Amazon hires. Maybe WISH can do a similar but less dramatic org shift.

WISH. Everyone seems to dislike this company except for some of the WSB herd. I still can’t understand why Jackie Reses, who was brilliant at Square, would join full time. She could have had any job she wanted. Any job. And she took a comp package that has $20-$30+ on the shares for payout. Is the goal to shape up the business and sell? Revamp strategy? You know she has a plan.

Nice, I started a little high at $4. Benefit I see compared to many other SPACS is that Ackman will more likely be buying an already profitable company. So there’ll be a reasonable growth compounding over five years to support equity/warrant appreciation.

At $16/share, if underwriters exercise their option for additional shares, CRBU has market cap of approx. $916m with cash of approx. $398m. Seems like a relative value compared to other CRISPR companies.